Bharat Seats Additional Capital Expenditure Approved for Maruti Suzuki Programs

Bharat Seats Ltd announced on August 4 through a stock exchange filing that its board of directors has approved an additional capital expenditure of INR 493.3 million. The investment will support new programs for Maruti Suzuki India Ltd as part of the company's regular business operations. The approved expenditure will be utilized at Bharat Seats' manufacturing facilities located in Kharkhoda and Navyani, India, strengthening production capabilities for upcoming vehicle programs.

The capital expenditure has been earmarked for Bharat Seats' plants at Kharkhoda and Navyani in Gujarat. The investment is intended to facilitate manufacturing requirements associated with new programs from Maruti Suzuki India while supporting the company's ongoing operational activities. The announcement was made through the company's regulatory filing and reflects board approval for expanding production infrastructure in line with customer requirements.

Bharat Seats operates as a joint venture involving Suzuki Motor Corporation of Japan, Maruti Suzuki India Ltd, Rohit Relan and Associates. The company was established to manufacture complete seating systems and automotive components for the automotive industry. Through this collaboration, Bharat Seats supplies seating solutions and related components to support vehicle production programs.

Frequently Asked Questions

What did Bharat Seats approve for Maruti Suzuki's new programs?
Bharat Seats approved an additional capital expenditure of INR 493.3 million to support new programs for Maruti Suzuki India at its Kharkhoda and Navyani manufacturing facilities. The investment was approved by the company's board of directors through a stock exchange filing and forms part of its ordinary business operations. Bharat Seats, a joint venture involving Suzuki Motor Corporation, Maruti Suzuki India Ltd, and Rohit Relan and Associates, manufactures complete seating systems and automotive components.